Objective-To relate dietary fat types to cognitive change in healthy community-based elders.
INTRODUCTION
The continuum of cognitive decline is important in dementia research; early decline is likely more amenable than clinical-level impairments to preventive or disease-modifying interventions. [1] [2] [3] Emerging evidence links dietary fat to late-life cognition; mechanisms may involve lipid profiles, 4, 5 inflammation [6] [7] [8] , cardiovascular health [9] [10] [11] [12] [13] [14] or neuroprotection 15, 16 . While these potential links are compelling, it is challenging to implement long-term randomized trials of varying intakes of major fatty acids (FA). Thus, consensus has emerged that more well-conducted, large-scale prospective studies with serial cognitive assessments are needed to address long-term relations of fats to cognitive aging. 17 We examined relations of major fat types to cognitive change over 4 years among ~6,000 older, community-dwelling participants of the Women's Health Study (WHS). We hypothesized: worse cognitive trajectories among women with higher vs. lower consumption of saturated FA (SFA) and trans fats ("bad fats") and better trajectories among women with higher vs. lower intake of monounsaturated FA (MUFA) and polyunsaturated FA (PUFA) ("good fats").
METHODS

Participants
Women's Health Study-The WHS was a randomized, double-blind, placebo-controlled 2×2 trial of aspirin and vitamin E supplements for primary prevention of heart disease and cancer 18 . From 1992-1995, 39,876 US female health professionals, aged ≥45 years, were randomized to one of four factorial groups. All were initially free of cancer (except nonmelanoma skin cancer), myocardial infarction, stroke, transient cerebral ischemia, liver disease, renal disease, peptic ulcer, and gout; women using corticosteroids, anticoagulants, or vitamin A and E supplements were excluded. Participants completed annual questionnaires updating information on health and lifestyle factors and clinical outcomes. The trial was completed on March 31, 2004 ; total follow-up was >99%. 19 The Cognitive Sub-study-In 1998, cognitive testing began among WHS participants aged ≥65 years. Of 7,175 age-eligible participants, 6,377 (89%) completed the initial assessment. Follow-up assessments occurred in 2000 and 2002: 5,692 (89%) of those who completed the initial assessment also participated in a second wave of assessment; 5,226 women (82%) participated in wave 3. The mean duration was 2 years between each wave. This study was approved by the Institutional Review Board of Brigham and Women's Hospital (Boston, MA).
The Cognitive Function Assessment
Cognitive exams were conducted via telephone by hypotheses-blind interviewers and consisted of: (1) Telephone Interview for Cognitive Status (TICS); (2) immediate and (3) delayed recall trials of the East Boston Memory Test; (4) delayed recall trial of the TICS 10-word list; and (5) category fluency. The TICS 20 (range: 0-41 points) is a test of general cognitive function, similar to the Mini-Mental State Examination 21 , and has high reliability and validity. The East Boston Memory Test (EBMT) 22 is a verbal (episodic) memory task of paragraph recall (range: 0-12 points) and involves immediate and 15-minute delayed recalls. The 15-minute delayed recall of the TICS 10-word list (range: 0-10 points) also assesses verbal memory. Lastly, category fluency (naming as many different animals as possible in one minute) captures language and executive functions such as abstract conceptualization and use of strategy. 23 
Reliability and Validity of Telephone Cognitive Assessments
To examine test-retest reliability, we administered the TICS twice after a one-month interval among 35 similar older women; the Pearson correlation was 0.7 (p<0.001). Regarding interrater reliability, intraclass correlations were >0.95 on each test. In a validity study, 61 welleducated older women completed both telephone-based and comprehensive (21-test) inperson assessments; the Pearson correlation was 0.81 between the global scores based on telephone vs. in-person tests. Also, expected relations of age and APOE ε4 24 to telephonebased cognition have been observed. In a further validation, cognitive impairment determined by telephone assessment was strongly associated with clinically-diagnosed dementia three years later 25 .
Ascertainment of Diet
A 131-item, semi-quantitative food-frequency questionnaire (FFQ) was administered at WHS baseline. For each item, portion size was specified, and participants were asked how often, on average, during the past year they consumed that amount. We computed nutrient scores by multiplying the frequency of consumption of each food unit by the nutrient content of that portion size according to US Department of Agriculture food composition tables, supplemented with information from manufacturers. Details on development, use, reproducibility and validity of the FFQ have been published previously. 26, 27 Ascertainment of covariates Information on covariates was obtained from annual questionnaires. Validation work demonstrated high accuracy of self-reported conditions (e.g., diabetes) 28 .
Population for Analysis
We excluded 194 women from the cognitive sub-study (n=6,377) with incomplete FFQ data. Thus, there were 6,183 participants for the analysis who completed initial testing; of these, 5,532 (89%) completed wave 2; 5,084 (82%) completed wave 3 (Supplemental Fig. 1 ).
Statistical Analysis
We categorized SFA, MUFA, PUFA (primarily comprised of linolenic acid), trans fat and total fat into quintiles. We conducted analyses using the multivariate nutrient density method, 29 in which fats are expressed as percentages of total energy and analyzed in the same model, along with protein as a percentage of energy and total energy intake (i.e., isocaloric); coefficients can be interpreted as the effect of substituting a specific amount of energy from fat for the same amount of energy from carbohydrates. This is the preferred analytic method for dietary components comprising relatively large proportions of calories 27, 29 . Primary outcomes were: global score, calculated by averaging z-scores from the TICS, delayed 10-word recall, immediate and delayed EBMT and category fluency tests; verbal memory, calculated by averaging z-scores of the EBMT and 10-word immediate and delayed recall trials. Outcomes were normally-distributed.
First, we examined mean scores across the three assessments, by fat quintiles, while adjusting for trial design variables (aspirin/vitamin E randomization status) as well as sociodemographic factors (age at initial testing, education, high household income, race) found to be the greatest potential confounders. Scores were repeated continuous outcomes, and we modeled the effect of fat intake using time-by-fat quintile interaction terms. Because the pattern of scores was non-linear (likely due to learning effects typically concentrated in the early test administrations, such as between the first and second interviews 30 ), we used general linear models of response profiles to estimate the means, and modeled timepoints as binary indicator variables (i.e., time 1, 2 or 3) 30, 31 . This approach imposes minimal structure on outcome trends, permits valid estimation of effects in non-linear data and can handle unbalanced patterns of longitudinal observations due to missing responses. We fitted models by maximum likelihood, incorporating longitudinal correlations within participants, using unstructured covariance matrices. For statistical testing, we used Wald tests 31 , and examined linear trends for fat quintiles continuously (participants in a given quintile were assigned the median value). Secondarily, because initial cognitive score was related to performance during follow-up, we repeated the above approach including interaction terms of initial (time 1) score-x-follow-up period (i.e., time 2 or 3). Analyses were conducted utilizing PROC MIXED in SAS, version 9.2 (SAS Institute, Inc., Cary, NC, USA).
We considered other variables (based on the literature and distributions in our sample) for the multivariable-adjusted models. Thus, for primary analysis, fully-adjusted models included: age at first cognitive interview (years), highest attained education (bachelor's degree or above vs. associate's degree), aspirin and vitamin E randomization assignment, race (white/non-white), household income (≥$50,000 per year/less), body mass index (BMI) (<25, 25.0-29.9, or ≥30 kg/m2), current smoking (yes/no), postmenopausal hormone use (ever/never), hypertension (self-reported history, use of antihypertensive medications, or systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg; yes/no), elevated cholesterol (self-reported history, use of lipid-lowering medications, or blood cholesterol >240 mg/dL; yes/no), depression (self-reported history; yes/no), diabetes (selfreported history; yes/no), daily alcohol consumption (≥1 drinks/day), and moderate or above frequency of exercise (≥1 times/week). Of note, self-reported household income (reported in categories as high as $100K+/yr or as low as <$10K/yr) was not available in 400 women; as our objective was to account for higher vs. lower income, these participants were placed in the reference (under $50K) group. Similarly, women missing self-reported white race or depression information (53 and 74, respectively) were placed in the non-white race (reference) and non-depressed (reference) categories, rather than excluded.
In a secondary analysis, we calculated odds ratios (ORs) of worst change in cognitive performance over 4 years (i.e., between the first and third testing waves). This was defined as being in the bottom 10% of the distributions of the global or verbal memory change scores. Such a population-based 10% cutpoint is common in cognitive research 32 and has high sensitivity and specificity for impairment. 33 Logistic regression models adjusted for covariates described above as well as the time between assessments (years). However, given the influence of initial score on the amount of absolute change that can be observed, we constructed an additional model including a term for residual initial score (after adjustment for intake of fats, protein, energy and the other covariates in linear regression), to account for initial performance while reducing bias. These analyses were restricted to the subset within our study population who completed both first and third testing waves (n=5,072 for global score; n=5,069 for verbal memory). We also addressed effects of substituting energy (e.g., 5%) from "good" fat (MUFA, PUFA) for that same energy amount from "bad" fat (SFA, trans fat) on the ORs (with confidence limits) of worst change, using the estimates, standard errors and covariances for the different fats obtained directly from the multivariate nutrient density models 27 .
We repeated the primary analysis models after excluding 455 women who developed cardiovascular disease (from the beginning of the WHS parent study to the end of the cognitive sub-study), as CVD is a major risk factor for late-life cognitive dysfunction 34 and strongly related to fat intake. 14, 35, 36 CVD included all medical record-confirmed non-fatal myocardial infarction, non-fatal stroke, cardiovascular-related deaths, or vascular disease as evidenced by coronary artery bypass graft or percutaneous transluminal coronary angioplasty or stenting. 19 Finally, we addressed possible interactions by two key factors: 1) age, as prior work 37 in a similar cohort revealed significant interactions between age and fat intake on cognitive decline; 2) history of elevated cholesterol, due to its central relation to fat intake.
RESULTS
Baseline characteristics
Women with higher intakes of all fats had higher BMI, higher prevalence of current smoking, and lower prevalence of moderate-or-above exercise. Women with higher SFA and MUFA intakes had lower prevalence of hypercholesterolemia and higher prevalence of daily alcohol consumption. Those with higher PUFA intake had higher prevalence of daily alcohol and lower prevalence of high income. Finally, women with higher trans fat intake had lower prevalence of high income and education (Table 1) .
Prospective analyses of cognitive change
Lower SFA and higher MUFA intakes were significantly related to more favorable global and verbal memory scores over time, after adjusting for socio-demographic variables (data not shown). Multivariable-adjusted results were similar (Figures 1 and 2 ). Wald p-values for linear trends of time-by-fat quintiles interactions illustrated significantly worse trajectories with higher SFA intakes for global score (p=0.008) and verbal memory (p=0.01). Similarly, trajectories were more favorable among those with higher MUFA intake, for global score (p<0.001) and verbal memory (p=0.009). There were no associations of PUFA, trans fat or total fat with cognitive change. Results were similar when models included adjustment for initial score-by-follow-up time interactions (Supplemental Figure 2 , results shown for SFA and MUFA only).
For further illustration of differences in cognitive outcomes by fat consumption, the mean differences in change over 4 years can be obtained directly from the models ( Table 2) . For example, multivariable-adjusted mean differences (95% confidence intervals [CI]) in 4-year change were −0.12 (−0.20, −0.03) standard units for global score and −0.13 (−0.23, −0.03) standard units for verbal memory, comparing the highest vs. lowest SFA quintiles. Comparing women in the highest vs. lowest MUFA quintile, the adjusted mean differences (95% CI) in change were 0.17 (0.07,0.26) standard units for global score and 0.16 (0.04,0.27) standard units for verbal memory. To help interpret these differences, we contrasted them with the estimate for the relation of age to cognitive change. Estimates for 4-year cognitive change comparing women in the highest vs. lowest SFA quintiles were similar to those for women 5-to-6 years apart at the start of testing (i.e., 5-6 added years of aging). By contrast, mean differences in change comparing the extreme MUFA quintiles were equivalent to 6-to-7 fewer years of aging.
Findings from analyses addressing worst cognitive change were consistent with results from primary analyses (Table 3) . Women with the highest vs. lowest SFA intake had 60-70% greater odds of worst change on global score and verbal memory. By contrast, women with the highest vs. lowest MUFA intake had 40-50% lower odds of worst change. Results were the same in models that adjusted for residual initial cognitive scores (data not shown). Finally, when estimating impacts of "good" fat vs. "bad" fat substitutions, we found that replacing 5% of energy from SFA with the same amount of energy from MUFA was associated with significantly lower odds of worst change: ORs were 0.47 (95% CI=0.25,0.89) for global score and verbal memory. There were no significant associations of Table 1 ).
In analyses excluding women with CVD, results were similar to those from the primary analyses: i.e., better trajectories in global score (n=5,717) and verbal memory (n=5,721) with lower SFA and higher MUFA intakes (p-linear-trends≤0.01; data not shown).
There were no significant three-way-interactions for age (above/below median age-at-initial testing [71 years]) or hypercholesterolemia with fat intake and time (data not shown). Of note, there appeared to be differences in initial global scores by SFA and MUFA intakesdriven by performance among persons below median age (e.g., p-interaction<0.01 for age-x-SFA intake on initial global score only; data not shown in Figure 1 ); no such differences or interactions were observed for verbal memory.
DISCUSSION
In this study of community-dwelling older women, higher saturated fat intake was associated with a poorer 4-year trajectory of global cognition and verbal memory. By contrast, higher MUFA intake was related to better global cognitive and verbal memory trajectory. The magnitude of relations found for extreme fat quintiles and cognitive change were equivalent to ~6 years of aging. Regarding worst global cognitive or verbal memory 4-year change, there was a 60-70% higher risk comparing the highest vs. lowest SFA quintiles, but a 40-50% lower risk comparing the highest vs. lowest MUFA quintiles. There were no associations of PUFA, trans fat or total fat with cognitive change.
The results regarding SFA are similar to those from prior large-scale studies [38] [39] [40] that examined "bad" fats with comparable methodology (e.g., adjusting for presence of other fats). For example, Morris et al. 38 observed that increasing SFA (p-trend=0.04) and trans fat intakes (p-trend=0.07) were linearly associated with faster global cognitive decline over 5.6 years among 2,560 age-65+ participants. Similarly, among 1,486 older women of the Nurses' Health Study with type 2 diabetes, higher SFA and trans intakes were associated with worse cognitive decline. 40 Finally, Eskelinen et al. 39 reported a 2-fold elevated risk of MCI (mild cognitive impairment) among 1,341 participants with high vs. low mid-life SFA intake; although the analysis was cross-sectional, the 21-year interval between diet assessment (mean age=50 years) and cognitive examination may have approximated prospective development of MCI. Regarding our null findings for trans fats, a potential explanation is their narrower distribution among these generally healthy women, compared to that in other cohorts 38, 40 . Although trans fat intake can be quite high among Americans, 41 the median percentage of energy from trans fat in the highest quintile for our cohort was 1.8%.
There are limited data available from larger-scale prospective studies regarding "good" fats. Solfrizzi et al. 42, 43 identified significant relations of higher MUFA and PUFA intakes to better cognitive aging. Devore et al. 40 observed inverse associations of higher MUFA consumption (p-trend=0.06) and higher intake of PUFA relative to SFA (p-trend=0.03) with global cognitive change among older diabetic women. Navqi et al. found significantly less 3-year memory decline among 482 Women's Health Initiative participants in the highest vs. lowest MUFA intake quartiles (SFA and trans fat were not significantly related to cognitive change; associations for PUFAs were not reported) 44 . Morris et al. 38 did not find significant associations of MUFA or PUFA with global cognitive decline, but estimates suggested inverse relations. Vercambre and colleagues 37 reported inverse relations of MUFA and PUFA to 5-year global cognitive decline among 2,551 women with CVD or risk factorsbut only among the oldest (73-91 years). Variability in study designs may partly explain inconsistency in findings. For example, investigators used different methods for defining fat types (e.g., total PUFA, PUFA from spreads 45 , linolenic acid (n-6 PUFA) only 46 ), may address different sub-groups (e.g., those with diabetes 40 ), or may not account for other fat types -as is recommended by experts in the field. 38 Finally, unsaturated fats may be more susceptible to random misclassification when using only a one-time or a lower-precision diet instrument.
Strengths of this study include its prospective design, large sample, well-validated FFQ, availability of numerous health and lifestyle covariates, high follow-up and focus on late-life cognitive change. Limitations should also be considered. First, repeated diet assessments were not available -increasing random measurement error, which could attenuate associations. Second, reverse causation is possible; however, there was a 5-year lag between the FFQ and initial cognitive assessment, and it seems unlikely that many women had substantial cognitive impairment at study entry, as all WHS participants had successfully completed a pre-randomization run-in phase that scrutinized compliance to assigned treatment. Third, generalizability of findings among these mostly Caucasian women is an issue. Although it seems unlikely that basic biological relations would differ greatly, further research on dietary fat and cognition among racial/ethnic minorities and men is needed. Lastly, residual confounding is possible, and the data should be interpreted with appropriate caution.
In conclusion, these data suggest that elevated SFA intake is related to worse late-life cognitive trajectory, and increased MUFA intake is related to better cognitive aging. Thus, decreasing SFA and increasing MUFA merit further consideration in promoting healthy cognitive aging, and dietary patterns that incorporate higher intake of "good" fats (e.g., Mediterranean) 47 should be further addressed in cognitive aging research. Findings from this large-scale prospective study help to address the identified need for an expanded, stronger evidence base on dietary factors and cognitive decline. 17, 48 
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. † SFA = saturated fatty acid; MUFA = mono-unsaturated fatty acid; PUFA = polyunsaturated fatty acid; Trans = trans fatty acid; Q1 = lowest quintile of intake; Q5 = highest quintile of intake; models adjusted for mean-centered age at initial cognitive assessment (continuous, in years), educational attainment (bachelor's degree or above versus associate's degree), race (white/non-white), annual household income (≥$50,000/less), randomized treatment assignment (aspirin, vitamin E), other fat intake, protein intake, total energy intake, body mass index (<25, 25.0-29.9, or ≥30 kg/m 2 ), current cigarette smoking (yes/no), postmenopausal hormone use (ever/never), history of hypertension (yes/no), history of elevated cholesterol (yes/no), history of depression (yes/no), history of diabetes (yes/no), daily alcohol consumption (yes/no), exercise (≥1 times per week/less), and all covariate-bytime interactions. P-values are from the Wald tests of interactions between fat type consumption level (medians-per-quintile) and time. N.B.: N=11 women were missing data at initial cognitive testing on components tests required to compute the global score. , and delayed recall trial of the TICS 10-word list; verbal memory score combines results of the immediate and delayed recall trials of EBMT and the TICS 10-word list; mean (SD) span between the 1 st and 3 rd assessments was 4.0 (0.3) years. Adjusted least-squares means were obtained from the repeated measures analysis models involving N=6,176 participants. † SFA = saturated fatty acid; MUFA = mono-unsaturated fatty acid; PUFA = polyunsaturated fatty acid; Trans = trans fatty acid; Q1 = lowest quintile of intake; Q5 = highest quintile of intake; models adjusted for mean-centered age at initial cognitive assessment (continuous, in years), educational attainment (bachelor's degree or above versus associate's degree), race (white/non-white), annual household income (≥$50,000/less), randomized treatment assignment (aspirin, vitamin E), other fat intake, protein intake, total energy intake, body mass index (<25, 25.0-29.9, or ≥30 kg/m 2 ), current cigarette smoking (yes/no), postmenopausal hormone use (ever/never), history of hypertension (yes/no), history of elevated cholesterol (yes/no), history of depression (yes/no), history of diabetes (yes/no), daily alcohol consumption (yes/no), exercise (≥1 times per week/less), and all covariate-bytime interactions. P-values are from the Wald tests of interactions between fat type consumption level (medians-per-quintile) and time. N.B.: N=7 women were missing data at initial cognitive testing on components tests required to compute the verbal memory composite. 
